SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-19-024405
Filing Date
2019-11-22
Accepted
2019-11-22 06:02:32
Documents
5
Period of Report
2019-11-22
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT f8k112219_delmarpharma.htm 8-K 34321
2 POSTER f8k112219ex99-1_delmar.htm EX-99.1 12130
3 POSTER f8k112219ex99-2_delmar.htm EX-99.2 4127
4 GRAPHIC ex99-1_001.jpg GRAPHIC 3317519
5 GRAPHIC ex99-2_001.jpg GRAPHIC 3112393
  Complete submission text file 0001213900-19-024405.txt   8906767
Mailing Address 12707 HIGH BLUFF DR., SUITE 200 SAN DIEGO CA 92130
Business Address 12707 HIGH BLUFF DR., SUITE 200 SAN DIEGO CA 92130 (858) 350-4364
DelMar Pharmaceuticals, Inc. (Filer) CIK: 0001498382 (see all company filings)

IRS No.: 990360497 | State of Incorp.: NV | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-37823 | Film No.: 191238630
SIC: 2834 Pharmaceutical Preparations